>
Sunday FULL SHOW: Newly Released & Verified Epstein Files Confirm Globalists Engaged...
Fans Bash Bad Bunny's 'Boring' Super Bowl Halftime Show, Slam Spanish Language Performan
Trump Admin Refuses To Comply With Immigration Court Order
U.S. Government Takes Control of $400M in Bitcoin, Assets Tied to Helix Mixer
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
Starlink smasher? China claims world's best high-powered microwave weapon
Wood scraps turn 'useless' desert sand into concrete
Let's Do a Detailed Review of Zorin -- Is This Good for Ex-Windows Users?
The World's First Sodium-Ion Battery EV Is A Winter Range Monster
China's CATL 5C Battery Breakthrough will Make Most Combustion Engine Vehicles OBSOLETE
Study Shows Vaporizing E-Waste Makes it Easy to Recover Precious Metals at 13-Times Lower Costs

(Natural News) Cannabinoids may show potential in the treatment of various skin diseases, according to a recent analysis. Health experts at the University of Colorado Anschutz Medical Campus examined current literature on the effects of cannabinoids on skin diseases and confirmed that pharmaceutical products containing the compound may prove effective in treating eczema, psoriasis, and both atopic and contact dermatitis.
According to senior author Dr. Robert Dellavalle, Associate Professor of Dermatology at the University of Colorado School of Medicine, the compound's most promising effect is addressing severe itch. The senior author cited one study where eight out of 21 patients who used a cannabinoid cream twice daily for three weeks were able to completely cure severe itching or pruritus. According to the study, cannabinoids helped relieve dry skin, which triggers itch in patients.
The research team also found that tetrahydrocannabinol, the active ingredient in marijuana, helped reduce swelling and inflammation in mice. The experts also noted that animal models of melanoma exhibited a significant inhibition of tumor growth following tetrahydrocannabinol injection. According to Dellavalle, the cannabinoid's anti-inflammatory properties may play a role in the beneficial effects of therapies using the compound. Dellavalle said the treatments used were cannabinoid drugs that spurred little to no psychotropic effects, indicating that they can be used in skin disorders. He also stressed that cannabinoids may be an effective alternative for patients who were non-responsive to other itch and skin disease therapies.